Browsing by Author "Kovacevic, Masa (55944572600)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2(2017) ;Peric, Stojan (35750481700) ;Rakocevic Stojanovic, Vidosava (6603893359) ;Mandic Stojmenovic, Gorana (55780903300) ;Ilic, Vera (56396353100) ;Kovacevic, Masa (55944572600) ;Parojcic, Aleksandra (55266544000) ;Pesovic, Jovan (15725996300) ;Mijajlovic, Milija (55404306300) ;Savic-Pavicevic, Dusanka (18435454500)Meola, Giovanni (7005543642)Neuropsychological examinations in myotonic dystrophy (DM) patients show a great variability of results from a condition of intellectual disability to the subtle cognitive impairments. It is unclear if different clusters of neuropsychological deficits appear in different phenotypes of DM, or if there are patients with no cognitive deficit at all. The aim of this study is to assess cognitive impairments among patients with different phenotypes of DM type 1 (DM1) and type 2 (DM2), and to potentially define cognitive clusters in these disorders. Study comprised 101 DM1 and 46 DM2 adult patients who were genetically confirmed. Patients underwent analysis of five cognitive domains (visuospatial, executive, attention, memory and language). Virtually all DM1 patients had cognitive defect with approximately 2–3 cognitive domains affected. On the other hand, one-third of DM2 patients had completely normal neuropsychological findings, and in other two-thirds approximately 1–2 domains were affected. Cluster analysis showed that in both diseases visuospatial and executive dysfunctions seemed to be the main cognitive defects, while memory and language impairments appeared in more severe phenotypes. Our results showed that a single form of DM1 or DM2 may consist of several cognitive clusters. Understanding of cognitive impairments in DM is very important to follow positive and side effects in ongoing and future clinical trials. © 2016, Springer-Verlag Italia. - Some of the metrics are blocked by yourconsent settings
Publication Heart involvement in patients with myotonic dystrophy type 2(2019) ;Peric, Stojan (35750481700) ;Bjelica, Bogdan (57194461405) ;Aleksic, Ksenija (57204954034) ;Kovacevic, Masa (55944572600) ;Cvitan, Edita (36782138400) ;Mandic Stojmenovic, Gorana (55780903300)Rakocevic Stojanovic, Vidosava (6603893359)Myotonic dystrophy type 2 (DM2) is a slowly progressive, autosomal-dominant disease. This is a multisystemic disorder that affects the heart, which is one of the main causes of morbidity and mortality in DM2. The aim of the study was to define cardiac impairments in patients with DM2 and its association with sociodemographic and clinical features of patients. This retrospective study comprised 62 adult patients with DM2 hospitalized at the Neurology Clinic, Clinical Center of Serbia from 2013 until 2018, who underwent electrocardiography (ECG) and echocardiography examinations. Hypertension was observed in 42% of DM2 patients. One-fifth of DM2 patients had bradycardia, while other conduction and rhythm impairments were rare. Only one patient had a pacemaker implanted because of the first degree AV block associated with incomplete left bundle branch block. Echocardiography showed diastolic dysfunction of the left ventricle in 44% of patients, while systolic dysfunction was found in only 4%. Cardiomyopathy was observed in 18% of patients, of whom three-fourth had dilated type. Cardiac conduction and rhythm defects are relatively rare in DM2, while diastolic dysfunction is common. This suggests that regular ECG and echocardiography screening is needed in DM2. Adequate therapy should be introduced in patients with DM2 on time to reduce the frequency of heart complications and to prevent premature death. © 2018, Belgian Neurological Society.
